Determination of Alprazolam and α-Hydroxyalprazolam in Plasma by High-Performance Liquid Chromatography

Analytical Sciences

Volumn 13, Issue 2, 1997, Pages 245-249

  Nagasaki, Takako ^a   Ohkubo, Tadashi ^b   Sugawara, Kazunobu ^b   Yasui, Norio ^b   Otani, Koichi ^b   Kaneko, Sunao ^b  

^a Goshogawara City Hospital   (Japan)

^b HIROSAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Alprazolam; High performance liquid chromatography; Pharmacokinetics; hydroxyalprazolam

Indexed keywords

LIQUIDS; METABOLITES; PATIENT MONITORING; PATIENT TREATMENT; PHARMACOKINETICS;

ACTIVE METABOLITES; ALPRAZOLAM; CONCENTRATION RANGES; HEALTHY VOLUNTEERS; INTERNAL STANDARDS; RELATIVE STANDARD DEVIATIONS; REVERSED PHASE HPLC; ULTRAVIOLET ABSORBANCE;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0000496872     PISSN: 09106340     EISSN: None     Source Type: Journal    
DOI: 10.2116/analsci.13.245     Document Type: Article

References (23)

1. G. W. Dawson, S. G. Jue and R. N. Brogden, Drugs, 132 (1984).
2. M. R. Liebowitz, A. J. Fyer, J. M. Gorman, R. Campeas, A. Levin, S. R. Davies, G. Geotz and D. F. Klein, J. Clin. Psychopharmacol., 6, 13 (1986).
3. J. Reich and W. Yates, Am. J. Psychiatry, 145, 590 (1988).
4. M. D. Warner, C. A. Peabody, H. A. Whiteford and L. E. Hollister, J. Clin. Psychiatry, 49, 148 (1989).
5. D. J. Greenblatt and C. E. Wright. Clin. Pharmacokinet., 24, 453 (1993).
6. V. H. Sethy and D. W. Harrus, J. Pharm. Pharmacol., 34, 115 (1982).
7. L. L. VonMoltke, D. J. Greenblatt, M. M. Cotreau-Bibbo, J. S. Harmat and R. I. Shader, Br. J. Clin. Pharmac., 38, 23 (1994).
8. D. J. Greenblatt, M. Divoll, L. J. Moschitto and R. I. Shader. J. Chromatogr., 25, 202 (1981).
9. T. R. Norman and G. D. Burrows, Int. Clin. Psychopharm., 5, 111 (1990).
10. A. B. Buch, D. R. VanHarken, R. J. Seidehamel and R. H. Barbhaiya, J. Clin. Pharmacol., 33, 1104 (1993).
11. S. R. McCormick, J. Nielsen and P. Jatlow, Clin. Chem., 30, 1652 (1984).
12. W. Rieck and D. Platt. J. Chromatogr., 578, 259 (1992).
13. R. L. Miller and C. L. DeVane, J. Chromatogr., 430, 180 (1988).
14. V. D. Schmith, S. R. Cox, M. A. Zemaitis and P. D. Kroboth, J. Chromatogr., 568, 253 (1991).
15. T. Ohkubo, R. Shimoyama and K. Sugawara, J. Pharm. Sci., 81, 947 (1992).
16. T. Ohkubo, R. Shimoyama and K. Sugawara, J. Chromatogr., 614, 328 (1993).
17. T. Ohkubo, T. Osanai, K. Sugawara, M. Ishida, K. Otani, K. Mihara and N. Yasui, J. Pharm. Pharmacol., 47, 340 (1995).
18. R. B. Schmith and P. D. Kroboth, Psychopharmacology, 93, 105 (1987).
19. D. A. Ciraulo, R. B. Raskin, J. P. Phillips, R. I. Shader and D. J. Greenblatt, J. Clin. Psychopharmcol., 10, 27 (1990).
20. V. D. Schmith, B. Piraino, R. B. Schmith and P. D. Kroboth, J. Clin. Pharmacol., 31, 571 (1991).
21. C. H. Asahan, A. G. Renwick, B. Macklin, V. F. Challenor and C. F. George. Br. J. Clin. Pharmacol., 31, 399 (1991).
22. C. H. Asahan, A. G. Renwick, D. G. Waller, V. F. Challenor, C. F. George and M. Amanullah, Clin. Pharmacol. Ther., 54, 329 (1993).
23. P. B. Watkins, Pharmacogenetics, 4, 171 (1994).